TERM ID="NYU_TERM_1" STRING="Gorlin syndrome" FREQUENCY=2 START=106 END=121 LEMMA="GORLIN SYNDROME" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_2" STRING="Gorlin syndrome" FREQUENCY=2 START=817 END=832 LEMMA="GORLIN SYNDROME" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_3" STRING="Gorlin syndrome Hereditary cancer syndromes" FREQUENCY=1 START=106 END=149 LEMMA="HEREDITARY CANCER SYNDROME GORLIN SYNDROME" LEMMA_FREQUENCY=1 HEAD_TERM="Hereditary cancer syndromes" HEAD_LEMMA="HEREDITARY CANCER SYNDROME"
TERM ID="NYU_TERM_4" STRING="Hereditary cancer syndromes" FREQUENCY=1 START=122 END=149 LEMMA="HEREDITARY CANCER SYNDROME" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_5" STRING="Recent work" FREQUENCY=1 START=481 END=492 LEMMA="RECENT WORK" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="Targeted therapy" FREQUENCY=1 START=0 END=16 LEMMA="TARGETED THERAPY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_7" STRING="Targeted therapy for hereditary cancer syndromes" FREQUENCY=1 START=0 END=48 LEMMA="HEREDITARY CANCER SYNDROME TARGETED THERAPY" LEMMA_FREQUENCY=1 HEAD_TERM="Targeted therapy" HEAD_LEMMA="TARGETED THERAPY"
TERM ID="NYU_TERM_8" STRING="affecting children" FREQUENCY=1 START=202 END=220 LEMMA="AFFECTING CHILD" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="clinical trials" FREQUENCY=1 START=931 END=946 LEMMA="CLINICAL TRIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="clinicians" FREQUENCY=1 START=1004 END=1014 LEMMA="CLINICIAN" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="cumulative morbidity" FREQUENCY=1 START=283 END=303 LEMMA="CUMULATIVE MORBIDITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="de novo counterparts" FREQUENCY=1 START=358 END=378 LEMMA="DE NOVO COUNTERPART" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_13" STRING="germline malignancies" FREQUENCY=1 START=747 END=768 LEMMA="GERMLINE MALIGNANCY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_14" STRING="hereditary cancer syndromes" FREQUENCY=2 START=21 END=48 LEMMA="HEREDITARY CANCER SYNDROME" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_15" STRING="hereditary cancer syndromes" FREQUENCY=2 START=855 END=882 LEMMA="HEREDITARY CANCER SYNDROME" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_16" STRING="identification" FREQUENCY=1 START=509 END=523 LEMMA="IDENTIFICATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_17" STRING="identification of molecular aberrations" FREQUENCY=1 START=509 END=548 LEMMA="MOLECULAR ABERRATION IDENTIFICATION" LEMMA_FREQUENCY=1 HEAD_TERM="identification" HEAD_LEMMA="IDENTIFICATION"
TERM ID="NYU_TERM_18" STRING="molecular aberrations" FREQUENCY=1 START=527 END=548 LEMMA="MOLECULAR ABERRATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_19" STRING="neurofibromatosis type" FREQUENCY=2 START=50 END=72 LEMMA="NEUROFIBROMATOSIS TYPE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_20" STRING="neurofibromatosis type" FREQUENCY=2 START=76 END=98 LEMMA="NEUROFIBROMATOSIS TYPE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_21" STRING="neurofibromatosis types" FREQUENCY=1 START=780 END=803 LEMMA="NEUROFIBROMATOSIS TYPE" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_22" STRING="oncology community" FREQUENCY=1 START=172 END=190 LEMMA="ONCOLOGY COMMUNITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_23" STRING="pathophysiology" FREQUENCY=1 START=969 END=984 LEMMA="PATHOPHYSIOLOGY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_24" STRING="targeted therapies" FREQUENCY=2 START=564 END=582 LEMMA="TARGETED THERAPY" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_25" STRING="targeted therapies" FREQUENCY=2 START=716 END=734 LEMMA="TARGETED THERAPY" LEMMA_FREQUENCY=3
